Mutation of RET proto-oncogene in Hirschsprung's disease and intestinal neuronal dysplasia.

World J Gastroenterol

Department of Pediatric Surgery, Children's Hospital, Medical College of Zhejiang University, Hangzhou 310003, Zhejiang Province, China.

Published: February 2006

AI Article Synopsis

  • The study explored the genetic link between Hirschsprung's disease (HD) and intestinal neuronal dysplasia (IND) in a Chinese population.
  • Genetic testing of blood samples revealed several mutations in the RET proto-oncogene specifically in HD patients, but not in IND patients or controls.
  • The findings indicate that RET mutations play a role in HD but highlight that IND is genetically distinct from HD.

Article Abstract

Aim: To investigate the genetic relationship between Hirschsprung's disease (HD) and intestinal neuronal dysplasia (IND) in Chinese population.

Methods: Peripheral blood samples were obtained from 30 HD patients, 20 IND patients, 18 HD/IND combined patients and 20 normal individuals as control. Genomic DNA was extracted according to standard procedure. Exons 11,13,15,17 of RET proto-oncogene were amplified by polymerase chain reaction (PCR). The mutations of RET proto-oncogene were analyzed by single strand conformational polymorphism (SSCP) and sequencing of the positive amplified products was performed.

Results: Eight germline sequence variants were detected. In HD patients, 2 missense mutations in exon 11 at nucleotide 15165 G-->A (G667S), 2 frameshift mutations in exon 13 at nucleotide 18974 (18974insG), 1 missense mutation in exon 13 at nucleotide 18919 A-->G (K756E) and 1 silent mutation in exon 15 at nucleotide 20692 G-->A(Q916Q) were detected. In HD/IND combined patients, 1 missense mutation in exon 11 at nucleotide 15165 G-->A and 1 silent mutation in exon 13 at nucleotide 18888 T-->G (L745L) were detected. No mutation was found in IND patients and controls.

Conclusion: Mutation of RET proto-oncogene is involved in the etiopathogenesis of HD. The frequency of RET proto-oncogene mutation is quite different between IND and HD in Chinese population. IND is a distinct clinical entity genetically different from HD.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4087911PMC
http://dx.doi.org/10.3748/wjg.v12.i7.1136DOI Listing

Publication Analysis

Top Keywords

exon nucleotide
24
ret proto-oncogene
20
mutation exon
16
mutation
8
mutation ret
8
hirschsprung's disease
8
disease intestinal
8
intestinal neuronal
8
neuronal dysplasia
8
ind chinese
8

Similar Publications

Four novel HLA-B noncoding variants detected by next-generation sequencing: HLA-B*07:02:107, -B*08:01:78, -B*15:01:89 and -B*52:01:58.

View Article and Find Full Text PDF

The HLA-DPB1*1498:01 allele differs from HLA-DPB1*02:02:01:01 by a single non-synonymous nucleotide change in exon 4.

View Article and Find Full Text PDF

The new HLA-B*38:01:26 allele showed one synonymous nucleotide difference compared to the HLA-B*38:01:01:01 allele in codon 101.

View Article and Find Full Text PDF

The HLA-C*01:250 allele differs from HLA-C*01:02:01:01 by a single non-synonymous nucleotide change in exon 7.

View Article and Find Full Text PDF

In this article, we present an approach to maximizing the splicing regulatory properties of splice-switching oligonucleotide (SSO) designed to regulate alternative splicing of PKM pre-mRNA. The studied SSO interacts with the regulatory element in exon 10 of PKM pre-mRNA and contributes to a significant reduction of PKM2 level with a simultaneous increase of the PKM1 isoform. This SSO forms a duplex not only with the regulatory fragment of exon 10 but also with a similar RNA fragment of intron 9.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!